SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-026944
Filing Date
2018-11-06
Accepted
2018-11-05 18:13:21
Documents
61
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rare-10q_20180930.htm 10-Q 2018749
2 EX-31.1 rare-ex311_7.htm EX-31.1 17457
3 EX-31.2 rare-ex312_8.htm EX-31.2 17456
4 EX-32.1 rare-ex321_6.htm EX-32.1 10887
5 GRAPHIC g1hj2rajg3iv000001.jpg GRAPHIC 43184
  Complete submission text file 0001564590-18-026944.txt   5824972

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rare-20180930.xml EX-101.INS 1170998
7 XBRL TAXONOMY EXTENSION SCHEMA rare-20180930.xsd EX-101.SCH 41884
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rare-20180930_cal.xml EX-101.CAL 48058
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rare-20180930_def.xml EX-101.DEF 105612
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rare-20180930_lab.xml EX-101.LAB 264755
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rare-20180930_pre.xml EX-101.PRE 208928
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36276 | Film No.: 181161035
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences